The EGFR inhibitor gefitinib has also been demonstrated to enhance ATRA-induced differentiation of leukemic cells [7] and to trigger the differentiation of AML cell lines (HL60, kasumi-1 and U937) that lack the expression of EGFR [8] when used alone. The gene discussed is EGFR; the disease is acute myeloid leukemia.